World of DTC Marketing

DECEMBER 29, 2021

The demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Semaglutide’s study results were enough to warrant plenty of hype for obesity treatment. The drug got a PR boost from Marc Andreessen, who called semaglutide a “silver bullet” and “miracle drug” for suppressing appetite. Unfortunately, the hype is going to exceed reality.

Side effects 191

Side effects Physicians Patients FDA 191

New to Medical Device Sales

DECEMBER 27, 2021

You can listen here: [link] You can watch here: [link] Today we are so fortunate to have the Director of Strategy and Talent for Medtronic Brain and Spine Therapies Jay Pendleton. Jay shares what he looks for in reps and what makes a great rep stand out. Jay has been in the industry 13+ years and is a wealth of knowledge so please take what he has to say to heart.

Medical sales 130

Medical sales Sales Medical Networking 130

Med Device Careers

DECEMBER 31, 2021

In this episode we sit down with Vince Burgess, Derrick Chou, and Peter Elia of Acutus Medical. Vince currently serves as the President and CEO where he brings over 30 years of experience in healthcare operations, marketing, business development and venture capital. Derrick, Acutus’ Chief Technology Officer has 9 years of experience in the design and development of pioneering medical technologies for the field of cardiac electrophysiology and imaging and has been a key inventor and technology le

Medical 52

Medical Healthcare Healthcare Marketing 52

Dinamic OR

DECEMBER 29, 2021

Hundreds of hospitals across the United States have temporarily postponed elective surgeries in deference to the fact that COVID-19 patients are occupying more beds in their facilities, and there simply isn’t room enough to accommodate patients requiring less urgent procedures. It’s also true that short-staffed healthcare facilities are overworked, and many staff are nearing the point of burnout.

Education 52

Education Healthcare Healthcare Management 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

World of DTC Marketing

DECEMBER 30, 2021

Routine cancer screening is essential to detect cancers early when it is most curable. The consequence of millions of people missing cancer screenings because of the COVID pandemic is a delay in detecting cancer, which results in cancer progressing to a more advanced stage. According to a study published in JAMA Oncology, a publication of the American Medical Association, nearly 22 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic.

Networking 187

Networking Physicians Education Patients 187

Pharmaceutical Representative Training

DECEMBER 28, 2021

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The 2021 pandemic has inspired pharmaceutical companies to reform their strategies for in-person sales and meetings.

Marketing 52

Marketing Food and Drug Administration Pharma Doctors 52

PharmaKinnex

DECEMBER 27, 2021

CASE STUDY First-Time Generic Product Launch Situation Product launch of a first-time generic product in the glaucoma market. Challenges. Different formulation than currently available reference branded product. Not available in every EMR platform initially. Need to re-create the market for this previously discontinued formulation. Approach. High potential targets were selected based upon their historical prescribing pattern of the branded reference drug.

Physicians 52

Physicians Marketing 52

Pharmatutor

DECEMBER 27, 2021

AROMATASE INHIBITORS IN BREAST CANCER. About Authors. MANISHA KOTADIYA*, JAYDEEP SAVALIYA. *Shree Swaminarayan Sanskar Collage of Pharmacy Zundal, Gandhinagar, Gujarat, Email Id: manishakotadiya3@gmail.com, FTF Pharma Pvt. Ltd. – Ahmedabad, Email ID: jaydeepsavaliya27@gmail.com. DOWNLOAD AS PDF. admin. Mon, 12/27/2021 - 15:34. Tags. Articles.

Pharma 52

Pharma 52

World of DTC Marketing

DECEMBER 27, 2021

When obesity has become a national health crisis caused by overeating and lack of exercise, a body positivity website has created free “Don’t Weigh Me” cards for patients who find stepping on the scale at the doctor’s office stressful. The group supports a “Health at Every Size” philosophy, based around the assumption that “the current practice of linking weight to health using BMI (body mass Index) standards is biased and unhelpful.” An analysis p

Doctors 43

Doctors Insurance Leads Patients 43

Clarify Health

DECEMBER 27, 2021

Clarify Health's Dr. Kenneth Park, Senior Vice President and General Manager of Life Sciences, moderated a Reuters' speaker series on the successful applications of precision insights to better understand patient cohorts, hyper-segment markets and healthcare providers (HCPs), and assess the cost of care. The panel consisted of leading life science industry experts, amongst which included: Bhash [.].

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Management 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaKinnex

DECEMBER 27, 2021

CASE STUDY Product Launch of New Dosage Strength Situation Product launch for new dosage strength of an existing product within the SNRI generic market. Challenges. Incomplete coverage of commercial insurances. Not available in every EMR platform initially. Changing physician prescribing habits to include new dosage strength in their treatment regiments.

Physicians 52

Physicians Insurance Medicine Marketing 52

PharmaKinnex

DECEMBER 27, 2021

CASE STUDY First-Time Generic Product Launch Situation Product launch of a first-time generic product in the glaucoma market. Challenges. Different formulation than currently available reference branded product. Not available in every EMR platform initially. Need to re-create the market for this previously discontinued formulation. Approach. High potential targets were selected based upon their historical prescribing pattern of the branded reference drug.

Physicians 52

Physicians Marketing Pharma 52

PharmaKinnex

DECEMBER 27, 2021

CAREERS Career Listing One Job Title. Job Location. Requirements (degree, skills). Morbi ut purus venenatis, feugiat purus nec, condimentum tortor. Proin ac lorem in lacus tristique molestie. Vivamus eu enim faucibus, vulputate leo eget, aliquet leo. Curabitur porta augue eu nibh iaculis faucibus. Pellentesque eleifend, tellus ut egestas imperdiet, lacus ante rhoncus lacus, ut cursus enim arcu eu elit.

40

40

PharmaKinnex

DECEMBER 27, 2021

CAREERS Career Listing Three Job Title. Job Location. Requirements (degree, skills). Morbi ut purus venenatis, feugiat purus nec, condimentum tortor. Proin ac lorem in lacus tristique molestie. Vivamus eu enim faucibus, vulputate leo eget, aliquet leo. Curabitur porta augue eu nibh iaculis faucibus. Pellentesque eleifend, tellus ut egestas imperdiet, lacus ante rhoncus lacus, ut cursus enim arcu eu elit.

40

40

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

PharmaKinnex

DECEMBER 27, 2021

CAREERS Career Listing One Job Title. Job Location. Requirements (degree, skills). Morbi ut purus venenatis, feugiat purus nec, condimentum tortor. Proin ac lorem in lacus tristique molestie. Vivamus eu enim faucibus, vulputate leo eget, aliquet leo. Curabitur porta augue eu nibh iaculis faucibus. Pellentesque eleifend, tellus ut egestas imperdiet, lacus ante rhoncus lacus, ut cursus enim arcu eu elit.

Pharma 40

Pharma 40

PharmaKinnex

DECEMBER 27, 2021

CAREERS Career Listing Two Job Title. Job Location. Requirements (degree, skills). Morbi ut purus venenatis, feugiat purus nec, condimentum tortor. Proin ac lorem in lacus tristique molestie. Vivamus eu enim faucibus, vulputate leo eget, aliquet leo. Curabitur porta augue eu nibh iaculis faucibus. Pellentesque eleifend, tellus ut egestas imperdiet, lacus ante rhoncus lacus, ut cursus enim arcu eu elit.

Pharma 40

Pharma 40

PharmaKinnex

DECEMBER 27, 2021

CAREERS Career Listing Three Job Title. Job Location. Requirements (degree, skills). Morbi ut purus venenatis, feugiat purus nec, condimentum tortor. Proin ac lorem in lacus tristique molestie. Vivamus eu enim faucibus, vulputate leo eget, aliquet leo. Curabitur porta augue eu nibh iaculis faucibus. Pellentesque eleifend, tellus ut egestas imperdiet, lacus ante rhoncus lacus, ut cursus enim arcu eu elit.

Pharma 40

Pharma 40

PharmaKinnex

DECEMBER 27, 2021

CAREERS Career Listing Four Job Title. Job Location. Requirements (degree, skills). Morbi ut purus venenatis, feugiat purus nec, condimentum tortor. Proin ac lorem in lacus tristique molestie. Vivamus eu enim faucibus, vulputate leo eget, aliquet leo. Curabitur porta augue eu nibh iaculis faucibus. Pellentesque eleifend, tellus ut egestas imperdiet, lacus ante rhoncus lacus, ut cursus enim arcu eu elit.

Pharma 40

Pharma 40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA